. However, despite being such an important phenotype, the causes leading to and the direct consequences resulting from CIN are poorly understood. Several mechanisms including a weakened spindle checkpoint, chromatid cohesion defects and also replication stress have been proposed to contribute to CIN, but none of these mechanisms can account for the widespread appearance of CIN in human cancer [4] [5] [6] . However, a major pre-stage of chromosome missegregation in cancer cells are so-called lagging chromosomes, which are the consequence of erroneous attachments of a single kinetochore to microtubules emanating from opposing spindle poles 7, 8 . In general, those erroneous kinetochore attachments also occur stochastically in the early phases of a normal mitosis, but are usually corrected before anaphase onset 8 . However, the details of this correction process are not well understood [8] [9] [10] [11] [12] and it seems that kinetochore attachment error correction is rarely inactivated in human cancer. It is, however, conceivable that increased rates of kinetochoremicrotubule mal attachments might overwhelm the capacity of the cellular error correction machinery. Indeed, this has been demonstrated for a subset of cancer cells exhibiting supernumerary centrosomes. In these cases, transient multipolar spindle intermediates can facilitate the generation of erroneous kinetochore attachments and, thus, promote the generation of lagging chromosomes despite the presence of error correction 13, 14 . However, because most cancer cells do not exhibit supernumerary centrosomes 15 , additional, yet unknown mechanisms promoting the generation of lagging chromosomes are likely to exist. Interestingly, in human cancer cells a number of established oncogenes and tumour suppressor genes are implicated in proper mitotic chromosome segregation 16 . For instance, PLK1 and aurora-A are centrosomal kinases involved in mitotic spindle assembly 17 , but the consequences resulting from their overexpression, which is often detected in human cancer cells 18, 19 , are unclear. Similarly, previous publications have reported on a requirement of the tumour suppressors CHK2 and BRCA1 for normal mitotic chromosome segregation 20, 21 . The mechanism of how the overexpression of these oncogenes or the loss of these tumour suppressor genes causes CIN remains an open question.
RESULTS
Increased mitotic microtubule plus-end assembly rates are characteristic for CRC cells exhibiting CIN We addressed the role of microtubule assembly dynamics within mitotic spindles as a possible and yet unexplored mechanism that could influence CIN in human cancer cells. To this end, we measured microtubule plus-end assembly rates in live cells during mitosis by tracking the microtubule end-binding protein EB3 fused to GFP (ref. 22 ). We used a panel of CRC cells, which can be categorized into chromosomally stable MIN/MSI cell lines with a near-diploid karyotype (HCT116, SW48 and RKO) and cell lines exhibiting CIN (SW837, LS1034, SW620, SW480, HT29 and CaCo-2). To ensure comparable measurements of the various cell lines, we synchronized cells in mitosis by using the small-molecule inhibitor dimethylenastron 23 (DME) targeting the mitotic kinesin Eg5 (also known as Kif11), which resulted in the formation of monopolar spindles 24 . Neither this synchronization step nor the expression level of EB3-GFP influenced microtubule plus-end assembly rates (Supplementary Figs 1a,b and 2e) . Intriguingly, we found that all CIN cell lines exhibited significantly increased microtubule assembly rates when compared with MIN/MSI cell lines or with non-transformed human RPE-1 cells (Fig. 1a) suggesting that abnormal microtubule plus-end assembly rates might be linked to CIN.
Increased mitotic microtubule plus-end assembly rates influence CIN
To investigate the relationship between increased microtubule assembly rates and CIN we restored normal microtubule assembly rates in CIN cells by partially lowering the expression of the microtubule polymerase ch-TOG (also known as CKAP5; Supplementary Fig. 1c ), which mediates the assembly of α v β-tubulin subunits at microtubule plus ends 25, 26 . Live-cell analyses of stable cell lines demonstrated that partial repression of CH-TOG was sufficient to restore normal microtubule assembly rates in CIN cells to a level typically seen in chromosomally stable cells (Fig. 1b) . Partial repression of CH-TOG does not affect normal cell cycle progression or cell viability ( Supplementary Fig. 3d ). Most importantly, karyotype analyses using chromosome counting and interphase fluorescence in situ hybridization revealed a significant reduction of karyotype variability and, thus, of CIN after restoration of normal microtubule plus-end assembly rates ( Fig. 1c and Supplementary Fig. 1d and Table 1 ). These results indicate that increased microtubule plus-end assembly rates can influence CIN in cancer cells.
Drug-mediated alterations in mitotic microtubule plus-end assembly rates affect karyotype stability
As another independent approach to restore normal microtubule assembly rates in CIN cells we used Taxol, a microtubule-binding drug known to suppress microtubule assembly, preferentially at the plus ends [27] [28] [29] . We identified sub-nanomolar concentrations of Taxol that were sufficient to suppress the increased microtubule assembly rates in different CIN cell lines without affecting cell viability or normal cell cycle progression (Fig. 1d ,e and Supplementary Fig. 1e ). Most strikingly, low-dose Taxol treatment significantly suppressed CIN ( Fig. 1f and Supplementary Fig. 1f and Table 1 ). Remarkably, removal of Taxol re-induced increased microtubule plus-end assembly rates and CIN in the same single-cell clones (Fig. 1e ,f and Supplementary Table 1 ). In addition, we used sub-nanomolar concentrations of nocodazole, a microtubule-binding drug known to have opposite effects on microtubule dynamics compared with Taxol 30 , and detected an increase in microtubule assembly rates and an induction of CIN in otherwise chromosomally stable HCT116 cells (Fig. 1h and  Supplementary Table 1) . Together, these results indicate that subtle alterations in microtubule plus-end assembly rates are sufficient to affect the numerical karyotype stability in cancer cells.
Overexpression of the oncogene AURKA or loss of the tumour suppressor gene CHK2 influences CIN by increasing mitotic microtubule assembly rates
To identify cancer-relevant genetic lesions that confer increased microtubule assembly rates we investigated the role of the most frequent genetic alterations found in CRC (summarized in Supplementary Fig. 2a ) previously implicated in mitotic processes 18, 19, [31] [32] [33] [34] [35] . Live-cell analyses of cells engineered to harbour these different genetic alterations ( Supplementary Fig. 2b ) showed that the overexpression of AURKA or loss of CHK2 increased microtubule assembly rates to a level typically found in chromosomally unstable CRC cell lines (Fig. 2a) . Moreover, single-cell clones derived from stable cell lines exhibiting these genetic lesions evolved a high karyotype variability and, thus, CIN ( Table 1 ). However, the increase in microtubule assembly rates was neither associated with supernumerary centrosomes ( Supplementary Fig. 2f ) nor with overt changes in other microtubule dynamics parameters such as overall dynamicity, frequency of catastrophe events or time spent paused (Supplementary Fig. 2g-i) . Importantly, restoration of normal microtubule plus-end assembly rates mediated by a partial repression of CH-TOG ( Table 1) . Thus, we demonstrate that overexpression of the oncogene AURKA or loss of the tumour suppressor gene CHK2 increases microtubule assembly and influences CIN in CRC cells.
Increased microtubule assembly rates are associated with transient mitotic spindle geometry defects
To investigate the link between increased microtubule assembly rates and chromosome missegregation we analysed the structure of mitotic spindles in cell lines overexpressing AURKA or deficient for CHK2. Interestingly, in both cases we found very similar abnormal mitotic spindle structures, which were suppressed on restoration of normal microtubule assembly rates by partial repression of CH-TOG (Fig. 3a-c) . Further live-cell microscopy analyses revealed that the spindle structure abnormalities were transient and associated with a timely delay in chromosome alignment (see examples in Supplementary Videos 1 and 2). Importantly, those cells eventually achieved full alignment of chromosomes and initiated anaphase, albeit at the expense of chromosome missegregation. The transient nature of spindle abnormalities in those cells prompted us to analyse the dynamic positioning of the spindle axes by detecting GFP-centrin as a marker for centrosomes in live cells (Fig. 3d) . In fact, during late prometaphase when the distance of the two centrosomes was maximal (Supplementary Videos 3 and 4) we found significantly increased angles of spindle axes and, thus, a misalignment of the mitotic spindle in cells exhibiting increased microtubule assembly rates (Fig. 3e) . This spindle mispositioning seen in live cells was no longer apparent in metaphase (Fig. 3e) observation of transient spindle geometry abnormalities in fixed cells. Remarkably, restoration of normal microtubule assembly rates by lowdose Taxol treatment suppressed the spindle mispositioning (Fig. 3f) ,
indicating that an increase in microtubule assembly rates can influence transient spindle geometry abnormalities during the early phases of mitosis. Increased microtubule plus-end assembly rates promote the generation of lagging chromosomes without interfering with error correction We investigated whether an increase in microtubule assembly associated with transient spindle geometry abnormalities might represent a cancer-relevant mechanism for the generation of lagging chromosomes. Indeed, the number of lagging chromosomes during anaphase was significantly increased in cells with increased microtubule assembly rates and suppressed when normal microtubule assembly rates were restored (Fig. 4a) . As lagging chromosomes can result from an impairment of error correction that is associated with increased microtubule-kinetochore attachment stability 8,10,36,37
, we determined the microtubule-kinetochore attachment stability by measuring microtubule turnover in live cells ( Supplementary  Fig. 4a-c) . Intriguingly, we found hyper-stable microtubulekinetochore attachments in cells with increased microtubule assembly rates, which were suppressed by restoration of proper microtubule assembly (Fig. 4b) . To test the possibility that increased microtubule assembly rates might interfere with error correction, we induced erroneous kinetochore attachments by a monastrol washout procedure, followed by a release of these cells into medium containing the proteasome inhibitor MG132 to provide extra time for error correction by prolonging metaphase as shown previously 38 . Importantly, cells with increased microtubule assembly rates were able to efficiently reduce the number of lagging chromosomes during anaphase, whereas MCAK -depleted cells, which are impaired in error correction [9] [10] [11] [12] , showed the persistence of lagging chromosomes even after prolonging the time for error correction ( Fig. 4c and Supplementary Fig. 4d ). Hence, despite the presence of hyper-stable microtubule-kinetochore attachments, the increase in microtubule plus-end assembly rates as an influencing factor for CIN does not interfere with error correction. Vice versa, both depletion of MCAK or APC, which reduces the turnover of kinetochoremicrotubules 10, 37 , or overexpression of MCAK in CIN cells, which promotes error correction 10 , caused no alteration in microtubule plus-end assembly rates ( Supplementary Fig. 4e-h ). Thus, increased microtubule assembly rates and impaired error correction, both of which lead to lagging chromosomes and CIN, seem to be separable mechanisms. As both conditions are associated with hyper-stable microtubule-kinetochore attachments we examined whether this might be associated with erroneous kinetochore attachments per se. To test this, we analysed kinetochore-microtubule turnover in chromosomally stable HCT116 cells after release from a monastrol block in the presence or absence of MG132. Although the microtubule assembly rates were not changed ( Supplementary  Fig. 4i ), the half-life of kinetochore-microtubules in bipolar spindles was significantly increased on induction of erroneous attachments and clearly suppressed after extended error correction ( Fig. 4d and Supplementary Fig. 4j ), suggesting that erroneous attachments might be associated with a higher stability per se. Thus, we conclude that increased microtubule assembly rates and impairment of error correction are separable mechanisms, both of which are associated with hyper-stability of erroneous microtubule-kinetochore attachments leading to the generation of lagging chromosomes.
The CHK2-BRCA1 tumour suppressor pathway negatively regulates the oncogene AURKA to ensure proper microtubule assembly rates
To investigate the cancer relevance of AURKA overexpression and loss of CHK2 as key mediators of increased microtubule assembly rates, we determined their expression in tumour tissues from CRC (n = 333 patients). We found a 40% frequency of AURKA overexpression and a 47% frequency for the loss of CHK2 (Fig. 5a ), which represents one of the most frequent genetic alterations in human CRC (ref. 31) . From 325 tumour samples that could be used to simultaneously detect AURKA and CHK2 expression, we calculated a proportion of 73% of the cases that exhibited at least one of the two lesions (Fig. 5b) . Moreover, individual tumour specimens exhibiting loss of CHK2 were found to be preferentially devoid of concomitant overexpression of AURKA (Fig. 5b) . Similarly, in a panel of CRC cell lines, increased microtubule assembly rates and CIN correlated with either overexpression of AURKA or a loss of CHK2 ( Supplementary  Fig. 5a ), suggesting possible redundant functional outcomes of these two genetic alterations. This prompted us to investigate a cross-talk of aurora-A and CHK2. Not surprisingly, overexpression of AURKA resulted in increased levels of active and auto-phosphorylated aurora-A kinase 39 localized at mitotic centrosomes, which was associated with increased phosphorylation of the centrosomal aurora-A target protein TACC3 (ref. 40 ; Supplementary Fig. 5b,c) . Intriguingly, however, loss of CHK2 resulted in a very similar increase in the proportion of active aurora-A at mitotic centrosomes and an increase in TACC3 phosphorylation without altering the overall level of aurora-A ( Fig. 5c and Supplementary Fig. 5d-g ). As the tumour suppressor BRCA1 and, more specifically, the CHK2-mediated phosphorylation of BRCA1 (on Ser 988) was shown to be crucial for proper mitotic progression 20, 21 , we investigated whether CHK2 might act on aurora-A through BRCA1. Indeed, cells expressing a non-phosphorylatable BRCA1 mutant 20,41 (S988A; Supplementary Fig. 6a ) showed an increase in active aurora-A at mitotic centrosomes, which was accompanied by an increase in microtubule assembly rates (Fig. 5d,e) . Moreover, in co-immunoprecipitation experiments, we detected an interaction of active aurora-A with BRCA1, which was strongly enhanced on loss of CHK2 or loss of the CHK2-mediated phosphorylation site on BRCA1 whereas the interaction of aurora-A with its cofactor TPX2 was not affected ( Supplementary Fig. 6b,c) . These results suggest that the tumour suppressor CHK2 restrains the activity of the oncogenic aurora-A kinase during mitosis through the phosphorylation of the tumour suppressor protein BRCA1 and indicate that the increase in aurora-A activity might be a key trigger for increased microtubule plus-end assembly rates and influences CIN in CRC cells.
Increased aurora-A kinase activity is a key trigger for increased microtubule assembly rates and influences CIN in CRC cells
To examine whether increased aurora-A activity is a general trigger for increased microtubule assembly rates in CRC cells, we partially inhibited aurora-A in CHK2-deficient HCT116 and SW620 cells using the small-molecule inhibitor MLN8054 (ref. 42) , which was indeed sufficient to suppress microtubule assembly rates (Fig. 6a ). In addition, we generated stable cell lines derived from CHK2-deficient HCT116 cells that expressed reduced levels of AURKA. This partial loss of aurora-A restored its proper centrosomal activity level ( Supplementary Fig. 7a-c) , normal microtubule assembly rates ( Fig. 6b) , normal mitotic spindle geometry (Fig. 6c) , timely mitotic progression ( Supplementary Fig. 7d ) and suppressed hyper-stability of kinetochore-microtubules ( Supplementary Fig. 7e ). Consequently, the generation of lagging chromosomes was inhibited (Fig. 6d) , which was associated with suppression of CIN ( Fig. 6e and Supplementary  Fig. 7f and Table 1 ). Importantly, partial repression of AURKA was also sufficient to restore normal microtubule assembly rates and to suppress CIN in various chromosomally unstable CRC cell lines irrespective of their genetic constitution but not affecting non-CIN cells (Fig. 6f,g and Supplementary Fig. 7g ,h and Table 1 ).
Thus, these findings demonstrate that increased microtubule assembly rates resulting in CIN and commonly seen in chromosomally unstable CRC cells are dependent on elevated aurora-A kinase activity. Moreover, CIN in those cancer cells can be experimentally suppressed by different means including treatment with low-dose Taxol, partial loss of the microtubule polymerase ch-TOG or partial inhibition of aurora-A.
Restoring proper microtubule assembly rates associated with a suppression of CIN accelerates tumour growth in vitro and in vivo
The identification of increased microtubule plus-end assembly rates as a factor influencing CIN in CRC cells and the ability to suppress this phenotype by various means enabled us to address the long-standing question of the impact of CIN on tumour growth. As a first step in this direction, we evaluated colony formation in soft agar, which reflects anchorage-independent cell growth in tumours. Unexpectedly, CHK2-deficient HCT116 and SW620 cells, in which increased microtubule assembly rates and CIN were suppressed either by treatment with low-dose Taxol, by partial repression of CH-TOG or by partial loss of AURKA, showed a significantly higher rate of colony formation in soft agar when compared with the respective cells with high CIN (Fig. 7a,b and Supplementary Fig. 8a-c) . Then, we investigated the consequence of CIN triggered by an increase in microtubule assembly rates on tumour growth in vivo. We found that xenograft tumours derived from SW620 cells with restored microtubule assembly rates and suppressed CIN, mediated either by partial repression of CH-TOG or AURKA, exhibited significant acceleration of tumour growth in vivo when compared with tumours showing increased microtubule assembly rates triggering CIN (Fig. 4c,d and Supplementary Fig. 8d,e) . Analyses of cells re-isolated from these xenograft tumours showed the maintenance of CIN suppression ( Supplementary Fig. 8g-i) . Moreover, direct comparison of xenograft tumours derived from isogenic HCT116 cells revealed that loss of CHK2, which is associated with increased microtubule assembly rates and CIN, caused reduced tumour growth when compared with tumour formation from parental cells (Supplementary Fig. 8f ). However, restoration of normal microtubule assembly rates and chromosomal stability in those cells accelerated tumour growth to a rate very similar to that of the chromosomally stable parental HCT116 cells (Fig. 7e and Supplementary Fig. 8f ). In contrast, xenograft tumours derived from chromosomally stable RKO cells with a partial loss of AURKA not affecting their stable karyotype did not result in acceleration of tumour growth in vivo, indicating that partial loss of AURKA does not alter the tumour growth of CRC cells per se (Fig. 7f) . Thus, our data revealed a detrimental effect of increased microtubule assembly rates influencing CIN on tumour growth in vitro and in vivo.
DISCUSSION
In cancer cells, CIN frequently correlates with the appearance of lagging chromosomes, which can persist either owing to impairment of error correction or owing to an increased rate of formation that might overwhelm the correction machinery [8] [9] [10] [11] [12] [13] [14] 36, 37 . So far, there is no evidence that error correction is frequently inactivated in human cancer cells (for example, ref. 43 ). However, our work now provides a mechanistic clue to the generation of lagging chromosomes as a source for CIN in CRC cells: an increase in microtubule plus-end assembly rates within mitotic spindles is frequently found in CRC cells and can trigger transient spindle geometry abnormalities that facilitate the generation of erroneous kinetochore attachments resulting in lagging chromosomes and influencing CIN (Fig. 8) . This mechanism is reminiscent of a subset of cancer cells with supernumerary centrosomes 15 that show transient multipolar spindle intermediates facilitating the generation of erroneous kinetochore attachments and leading to chromosome missegregation 13, 14 . It is important to note that chromosome missegregation on an increased rate of erroneous kinetochore attachments can occur in the absence of centrosome amplification and in the presence of functional error correction. It is, nevertheless, associated with a decrease in kinetochore-microtubule turnover, raising the possibility that hyper-stability of the kinetochore attachments might be related to the erroneous state of the attachment per se. In fact, increasing the number of erroneous attachments on monastrol washout decreases kinetochore-microtubule turnover, whereas decreasing mal attachments on prolonging error correction increases the turnover of kinetochore-microtubules. It is not yet clear whether erroneous kinetochore attachments, possibly mediated by abnormal tension within the kinetochore 7 , are intrinsically more stable, but it would explain why conditions that induce erroneous kinetochore attachments without having an obvious function in error correction (for example, APC) are also associated with an increase the stability of microtubule-kinetochore attachments 37 . Our finding of an increase in microtubule assembly rates as a mechanism influencing CIN is highly cancer-relevant. Genetic alterations triggering this phenotype including an overexpression of AURKA or a loss of CHK2 were found in about 70% of primary colorectal carcinomas and are also frequent in other types of cancer 18, 20, 44 . Thus, an increase in microtubule assembly rates, together with cancer-associated centrosome amplification, which can also be driven by overexpression of AURKA in certain cell types 45 , might represent an important mechanism resulting in lagging chromosomes and CIN in human cancer cells.
It is not yet clear how elevated aurora-A activity causes an increase in microtubule plus-end assembly rates. Interestingly, increased microtubule assembly rates can be efficiently suppressed by repression of CH-TOG suggesting that this microtubule polymerase might be a target for aurora-A. In fact, the recruitment of ch-TOG to mitotic spindles is positively regulated by aurora-A-mediated phosphorylation of the adaptor protein TACC3 (refs 40,46-48) and we detected an increase in this TACC3 phosphorylation in cells with increased microtubule assembly rates. Moreover, increased microtubule assembly rates in CIN cells can also be suppressed by partially depleting TACC3 (our unpublished results), indicating that aurora-A might hyper-activate the TACC3-ch-TOG axis. In this regard, it is of note that not only an overexpression of AURKA (ref. 18 ), but also of TACC3 and CH-TOG has been linked to the etiology of various human cancers 49, 50 , supporting a possible link between a general hyper-activity of this microtubule plus-end assembly pathway and CIN in cancer cells.
Given the fact that we identified a new mechanism influencing CIN in CRC cells that can be suppressed by various means, we were in a position to investigate the consequences of increased microtubule assembly rates and CIN on tumour growth. As a first step into this important direction, we found that CIN cells with increased microtubule assembly rates exhibit reduced tumour growth in vitro and in vivo when compared with tumours derived from cells with proper microtubule assembly rates and suppressed CIN. Although surprising at first glance, these results might reflect a detrimental effect of aneuploidy on cell proliferation, which might be mediated by altered metabolic properties and proteotoxic stress as shown previously for yeast and mouse embryonic fibroblasts harbouring defined trisomies [51] [52] [53] . This raises the question of why cancer cells select for lesions such as AURKA overexpression or loss of CHK2 causing increased microtubule assembly rates and CIN. One plausible hypothesis might be that CIN can provide a high adaptation capability, which may be crucial for tumour initiation and progression 2, 3, 54 .
METHODS
Methods and any associated references are available in the online version of the paper. 55 were a gift from B. Vogelstein (John Hopkins University, Baltimore, Maryland, USA). Colorectal cancer cell lines were from ATCC. SW48 and derivative cell lines carrying KRAS mutations were from HORIZON and were generated by HORIZON's proprietary adeno-associated virus (AAV) gene targeting technology GENESIS. All cell lines were cultured at 37 • C with 5% CO 2 in RPMI1640 or DMEM medium containing 10% fetal calf serum, 1% glutamine, 100 µg ml −1 streptomycin and 100 U ml −1 penicillin (Invitrogen). All cell lines were tested for mycoplasma contamination.
Note: Supplementary Information is available in the online version of the paper

METHODS
Human cell lines. HCT116 and isogenic CHK2-deficient cells
cDNAs. HA-tagged BRCA1 cDNAs (wild type, S988A, S988E) cloned into pcDNA3 were provided by J. Chung (NIH, Bethesda, Maryland, USA) 41 . Full-length human AURKA cDNA cloned into pcDNA3 (Invitrogen) was a gift from M. Eilers (Würzburg). Reconstitution of CHK2 expression was carried out using pCEF-CHK2 and pcDNA3-CHK2 vectors as described previously 20 . HA-tagged human PLK1 cloned into pcDNA3 and pCMVflag-Plk4 were gifts from I. Hoffmann (DKFZ, Heidelberg, Germany). For live-cell microscopy, pEGFP-EB3 (ref. 22 ) was used to detect microtubule plus-end tips. Plasmids for expression of GFP-tagged centrin and RFP-tagged H2B were gifts from S. Duensing (University of Heidelberg, Germany) and O. Sibon (University of Groningen, The Netherlands), respectively. Full-length human MCAK was cloned into pcDNA3 (Invitrogen).
shRNAs and siRNAs. The following short hairpin sequences were cloned into the pSuper-Retro vector carrying a puromycin resistance marker and were used to generate stable cell lines: CHK2 no. 1: 5 -GCCUUAAGACACCCGU GGC-3 ; CHK2 no. 2: 5 -GAACCUGAGGACCAAGAAC-3 ; AURKA: 5 -GGC AACCAGUGUACCUCAU-3 ; CH-TOG: 5 -GAGCCCAGAGUGGUCCAAA-3 .
shRNA sequences targeting BRCA1 and the shRNA resistant mutants of BRCA1 and of CHK2 were previously described 20 . The control scrambled shRNA sequence with no target in the human genome was: 5 -CAUAAGCUGAGAUACUUCA-3 . For transient siRNA transfections, the following siRNA sequences were used: CHK2: 5 -CCUUCAGGAUGGAUUUGCCAAUC-3 ; CH-TOG: 5 -GAG CCCAGAGUGGUCCAAA-3 ; TACC3: 5 -GUGGAUUACCUGGAGCAGU-3 ; APC: 5 -AAGACGUUGCGAGAAGUUGGA-3 ; TP53: 5 -GUAAUCUACUGGGA CGGAA-3 ; MCAK : 5 -GCAGGCUAGCAGACAAAU-3 ; LUCIFERASE: 5 -CUU ACGCUGAGUACUUCGAUU-3 .
Transfections and generation of stable cell lines. Transient DNA transfections
were carried out by using PEI (Sigma) or by electroporation using a BioRad electroporator (BioRad) at 300 V and 500 µF (HCT116, SW48, SW620, SW837, LS1034), 220 V and 950 µF (HT29), and 200V and 950 µF (RKO). All siRNA transfections were carried out using Interferin transfection reagent (Polyplus) according to the manufacturer's instructions. Stable transfections were carried out using Metafectene (Biontex) using the protocol from the manufacturer followed by selection in medium containing 300 µg ml −1 G418 or 1 µg ml −1 puromycin. Single-cell clones were isolated, expanded and further analysed. The generation of stable HCT116 cell lines with low CHK2 expression (+ CHK2 shRNA) and cell lines in which CHK2 expression was reconstituted (CHK2 knockdown plus shRNA resistant CHK2 or CHK2 −/− cells plus CHK2 wild type) and cell lines with reduced BRCA1 expression (HCT116 + BRCA1 shRNA) were described in detail previously 20 . Stable colorectal cancer cell lines expressing shRNAs targeting CH-TOG or AURKA were generated by stable transfection of cells with pSuperRetro-CH-TOG and with pSuper-Retro-AURKA, respectively and single-cell clones were subsequently selected in medium containing 1 µg ml −1 puromycin. HCT116 cell lines stably expressing pcDNA-AURKA were selected in medium containing 300 µg ml −1 G418.
Cell treatments and cell cycle synchronization. To synchronize cells in G2 or
in mitosis, cells were first synchronized at G1/S by a double thymidine block and released into fresh medium. Six hours after the release, cells were in G2 as verified by FACS analyses and 8-9 h after release cells enter mitosis and various phases of mitosis could be observed. To block progression of mitosis beyond metaphase, 6 h after release from the thymidine block, cells were treated with 25 µM MG132 for an additional 2.5 h. To inhibit aurora-A activity, cells were treated with MLN8054 (ref. 42 ) at concentrations up to 0.5 µM. To restore proper microtubule plus-end growth rates low MLN8054 concentrations of 0.25 µM that partially inhibit aurora-A were used.
Immunofluorescence microscopy. To visualize mitotic spindles, kinetochores and centrosomes cells were fixed with 2% p-formaldehyde in PHEM (60 mM PIPES, 27 mM HEPES, 10 mM EGTA, 4 mM MgSO 4 , pH 7.0) followed by treatment with methanol at −20 • C for 5 min. For detecting centrosomal aurora-A, cells were fixed with methanol for 6 min. The following antibodies and dilutions were used for immunofluorescence microscopy experiments: anti-α-tubulin (1:700, B-5-1-2, Santa Cruz), anti-centromere (CREST, 1:1,000, Europa Bioproducts), anti-aurora-A (1:500, H130, Santa Cruz), anti-phospho-aurora-A (pT288, 1:200, Cell Signaling), anti-γ-tubulin (1:500, GTU-88, Sigma Aldrich), anti-centrin-2 (1:250, Abcam). Secondary antibodies conjugated to Alexa Fluor-488/-594 (1:1,000, Molecular Probes) were used. Microscopy of fixed cells was performed on a Leica DM6000B microscope (Leica) equipped with a CCD (charge-coupled device) camera (Orca-II-ERA, Hamamatsu) or using a DeltaVision-ELITE microscope (Applied Precision/GE Healthcare) equipped with a CoolSnap-HQ2 camera (Photometrics). Images were recorded with a Z-optical spacing of 0.2 µm, deconvolved and analysed using the Leica LAS-AF software (Leica) or the SoftWorx 5.0 (Applied Precision) software. Pixel quantification of centrosomal signals was carried out using the Leica LAS-AF and ImagePro software packages (Leica; MediaCybernetics) and normalized to signal intensities derived from centrosomal signals for centrin-2. Representative examples of immunofluorescence experiments that are shown in the figures were repeated at least 3 times.
Measurement of microtubule plus-end assembly rates. Microtubule plus-end
assembly rates were determined by tracking EB3-GFP protein in living cells 22, 56 . Cells were transfected with pEGFP-EB3 (provided by L. Wordeman, University of Washington, Seattle, Washington, USA), seeded onto glass-bottom dishes (Ibidi) and after 48 h cells were treated with the Eg5 (Kif11) inhibitors monastrol (67 µM, Sigma) 24 or dimethylenastron (DME; 2 µM; Calbiochem) 23 for 2 h or left untreated. This synchronization step was useful to ensure measurements of mitotic spindles in the same mitotic phase and did not affect the plus-end growth rates per se. Four sections with a Z-optical spacing of 0.4 µm were taken every 2 s using a Deltavision ELITE microscope equipped with an Olympus ×60, 1.42 NA objective and a CoolSnap-HQ2 (Photometrics) or a PCO Edge sCMOS camera (PCO) at 37 • C, 5% CO 2 . Images were deconvolved using the SoftWorx 5.0/6.0 software (Applied Precision). Average assembly rates (micrometres per minute) were calculated based on data retrieved for 20 individual microtubules per cell and a total of 10-60 cells were analysed in 3-4 independent experiments.
Low-dose Taxol treatment. To identify low, sub-nanomolar concentrations of
Taxol that are sufficient to reduce the increased microtubule growth rate of SW620, SW480, SW837, HCT116-CHK2 −/− and HCT116-AURKA cells to a level comparable to HCT116 cells without the enhanced microtubule growth phenotype, increasing, sub-nanomolar concentrations (0.05-0.5 nM) of Taxol (Sigma) were used in EB3-GFP microtubule assembly assays. The ascertained doses were used to generate single-cell clones for karyotype analyses. Subsequently, these Taxol-treated cell clones were grown for an additional 30 generations in the absence of Taxol before the karyotypes were determined again.
Low-dose nocodazole treatment.
To identify concentrations of nocodazol that increase microtubule assembly rates, HCT116 cells were treated with various subnanomolar concentrations (0.5-2.5 nM) of nocodazol (Sigma) before performing EB3 tracking in live cells. For karyotype analyses, single-cell clones derived from HCT116 cells were grown in 0.5 nM nocodazol for 30 generations.
Measurements of the half-life of kinetochore microtubule turnover. Cells were transfected with plasmids expressing PA-GFP-tubulin and EB3-RFP to enable the laser to be focused on the kinetochore fibres before photoactivation. Late prometaphase cells were photoactivated on one side of the bipolar spindle with a 405 nm laser on a microscope imaging system equipped with a CCD camera and a ×60 1.4 NA lens (Olympus) and a QLM laser module (Personal Deltavision; Applied Precision/GE Healthcare). Images were collected using adaptive frame rates for a period of 5 min post activation. Fluorescence intensity was measured and each time point was corrected for photobleaching (the decrease over time in the fluorescence of a photoactivated mark generated in Taxol-treated cells). Each time point was also adjusted for incorporation of free photoactivated tubulin dimers using a reference point on the equivalent opposite side of the mitotic spindle 20 . Fluorescence values were normalized to the first time-point after photoactivation for each cell and the average intensity at each time point was fitted to a two-phase exponential decay curve using Prism (GraphPad Software) in which the normalized fluorescence (F) is described by: F = A1exp(−k 1 t) + A2exp(−k 2 t). A1 represents both the rapid turnover of nonkinetochore microtubules and instantaneous diffusion of photoactivated dimers and A2 represents the contribution of stable kinetochore fibres, k 1 and k 2 are their respective rate constants of turnover, and t is the time after photoactivation. The turnover half-life for each process was calculated as ln2/k for each phase.
Determination of microtubule dynamicity. Cells were transfected with a plasmid expressing EB3-RFP and treated with 67 µM monastrol (Sigma). Microtubule plus tips were automatically tracked using plusTipTracker software as described previously 57 and overall dynamicity (collective displacement of all gap-containing tracks over their collective lifetimes), the percentage of time paused (total time all microtubules spend in gap over the total time all tracks exist) and the catastrophe frequency (1/mean(T ), where T is the lifetime (in minutes) of the growth subtrack just before the catastrophe) were determined. Rescue events could not be reliably calculated owing to the interference from the high density of tips in the monoasters.
Determination of mitotic timing. For live-cell analyses, cells were seeded on glass-bottom dishes (Ibidi) and transfected with H2B-GFP-expressing plasmids. Cells were followed by time-lapse microscopy at 37 • C and 5% CO 2 using a Leica DMI6000B (Leica). Image stacks were recorded every 2 min using a Hamamatsu EM-CCD camera (Hamamatsu) with a Z-optical spacing of 1 µm. Images were deconvolved and further processed using the Leica LAS-AF (Leica) or the SoftWorx 5.0/6.0 (Applied Precision) software. The time from nuclear envelope breakdown (loss of the smooth appearance of the nucleus) until the beginning of anaphase (start of chromosome movement to the poles) was determined and box and whisker plots were calculated from at least 50 recorded cells using the Prism software package, version 4 (GraphPad Software).
Determination of spatial centrosome positioning. Cells were transfected with pcDNA-RFP-H2B (to detect chromosomes; a gift from O. Sibon, University of Groningen, The Netherlands) and pEGFP-centrin (to detect centrioles and, thus, centrosomes; a gift from S. Duensing, University of Heidelberg, Germany) and seeded on glass-bottom dishes (Ibidi). Asynchronously growing cells were followed by time-lapse microscopy at 37 • C and 5% CO 2 using a DeltaVision-ELITE microscope (Applied Precision/GE Healthcare). Image stacks were recorded every minute using a PCO Edge sCMOS camera (PCO) with a Z-optical spacing of 1 µm. Images were deconvolved and further processed using the SoftWorx 6.0 (Applied Precision) software. When the separation of the two mother centrioles was maximal (indicating maximal separation of the two centrosomes, see also: Supplementary Videos 3 and 4), the spatial positioning of the centrosomes was determined by measuring the angle between the centrosome axis and the growth surface (substratum) considering the distance between both mother centrioles and the height from the growth surface to the centrosome in Z-optical spacing planes following the mathematic formula α = (sin α × 180 • )/π (see also Fig. 3d ). Box plots with mean values were calculated from cells in prometaphase and metaphase using the Prism software package, version 4 (GraphPad Software).
Detection of centrosome amplification. For quantification of centrosome amplification, asynchronously growing HCT116 parental cells, HCT116-CHK2 −/− and AURKA-overexpressing cells, respectively, were fixed with 2% p-formaldehyde in PHEM (60 mM PIPES, 27 mM HEPES, 10 mM EGTA, 4 mM MgSO 4 , pH 7.0) followed by treatment with methanol at −20 • C for 5 min. Subsequently, the cells were stained for γ-tubulin (1:500, GTU-88, Sigma-Aldrich) to visualize centrosomes and with Hoechst (Hoechst 33342, 1:10,000, Biomol) to identify nuclei in interphase cells. As a positive control, HCT116 cells were transiently transfected with pCMVflag-PLK4 (provided by I. Hoffmann, DKFZ, Heidelberg, Germany), and 48 h after transfection, interphase cells with more than two γ-tubulin-positive signals were evaluated.
Determination of lagging chromosomes. To detect lagging chromosomes in
anaphase, cells were transfected with control or CH-TOG siRNAs and subsequently synchronized in G1/S phase by a double thymidine block. Cells were released into medium for 8-9 h to accumulate cells in anaphase. Cells were analysed by immunofluorescence microscopy detecting CREST-positive chromosomes. Only chromosomes that were clearly separated from the two pole-oriented chromosome masses were counted as 'lagging chromosomes' . For the experiments in which the time for error correction was prolonged, cells were transfected with siRNAs targeting CHK2, MCAK or luciferase. After 48 h, cells were treated with 2 µM DME or 67 µM monastrol for 3 h, released from the block and fixed after 75 min when cells were mostly in anaphase. To prolong the time for error correction, cells were released from the DME/monastrol block into medium containing 10 µM MG132. After an additional 2.5 h, MG132 was washed out and cells were fixed 50 min later when they were mostly in anaphase.
Western blotting. Cells were lysed in lysis buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 5 mM EDTA, 5 mM EGTA, 1% (v/v) NP-40, 0.1% (w/v) SDS, 0.1% sodium desoxycholate, protease inhibitor cocktail (Roche) and phosphatase inhibitor cocktail (Roche)). Proteins were resolved on 7.5%, 10% or 12% SDS polyacrylamide gels and blotted onto nitrocellulose or PVDF membranes using semi-dry or tankblot procedures. For western blot experiments, the following antibodies and dilutions were used: anti-CHK2 (1:800, DCS-270, Santa Cruz), anti-β-actin (1:40,000, AC-15, Sigma), anti-BRCA1 (1:500, C-20 or D-9, Santa Cruz), anti-aurora-A (1:2,000, H130, Santa Cruz), anti-phospho-aurora-A (1:2,000, pT288, Cell Signaling), antiphospho-aurora-A, -B, -C (1:2,000, pT288, pT232, pT198, Cell Signaling), anti-Tpx2
(1:1,000; 18D5, Santa Cruz), anti-α-tubulin (1:2,000, B-5-1-2, Santa Cruz), anti-PLK1 (1:1,000, F-8, Santa Cruz), anti-p53 (1:1,000; Ab-2, Oncogene), anti-MCAK (1:250; provided by L. Wordeman, University of Washington, Seattle, Washington, USA), anti-Axin-2 (used to verify the repression of APC; 1:1,000; Cell Signaling), anti-TACC3 (1:1,000; H300, Santa Cruz), anti-phospho-TACC3 (Ser 558, 1:1,000, D8H10, Cell Signaling), anti-CH-TOG (1:1,000; H4, Santa Cruz), secondary antibodies conjugated to horseradish peroxidase (1:10,000, Jackson ImmunoResearch). Proteins were detected by enhanced chemoluminescence. Quantification of western blot bands was performed using the ImageJ software (NIH). Representative examples of western blots that are shown in the figures were repeated at least 3 times.
Immunoprecipitation. Cells were lysed in 50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.25% NP-40, 10% glycerol, 1 mM dithiothreitol, protease inhibitor and phosphatase inhibitor cocktails (Roche). Lysate (2 mg) was incubated with 1.5 µg anti-BRCA1 (D-9, Santa Cruz) or anti-Tpx2 (18D5, Santa Cruz) antibodies and immunocomplexes were precipitated using protein-G Sepharose beads (GE Healthcare).
FACS analyses and determination of the mitotic index. Cells were fixed in 70% ethanol overnight at 4 • C and resuspended in propidium iodide (5 µg ml −1 ) and RNaseA (1 µg ml −1 ) in PBS. FACS analyses were performed on a BD FACSCANTO II (Becton Dickinson) and 10,000 events were counted. Data analyses were performed using the BD FACSDIVA software (Becton Dickinson). Representative examples of cell cycle profiles that are shown in the figures were repeated at least 3 times. The mitotic index was determined by staining of fixed cells with anti-MPM2 (1:1,600, Millipore) and secondary antibodies conjugated to Alexa Fluor-488 (1:2,000, Molecular Probes) as described previously 20 .
Karyotype analyses. Single-cell clones were generated and chromosome spread analyses and chromosome counting in individual cells was performed after 30 generations as described previously 20 and the proportion of cells with chromosome numbers deviating from the modal was determined. The chromosome number variability generated in single-cell clones within a defined time span and that showed deviation by up to 5 chromosomes was taken as a measure for CIN.
CEP-FISH analyses.
Chromosome number variability was also determined by fluorescence in situ hybridization (FISH) using Aquarius Satellite Enumeration probes (Cytocell). Cells were washed with PBS and incubated in 40% (v/v) RPMI-1640 at room temperature for 15 min. Cells were then fixed in Carnoy's solution (methanol-acetic acid (3:1)). FISH was performed using α-satellite probes specific for chromosomes 7 and 15 (Cytocell) according to the manufacturer's protocol. FISH images were acquired as 0.5 µm optical sections with the ×60 1.4 NA objective and chromosome signals in at least 100 nuclei were determined.
Human tumour samples and immunohistochemistry analyses. Tissue samples from 333 primary human colorectal adenocarcinomas were investigated by using tissue microarrays. Microarray construction and immunohistochemical analyses were carried out as described previously 58 using a monoclonal anti-CHK2 antibody (DCS-273, 1:250, Sigma) and an anti-aurora-A antibody (clone JLM28, 1:50, Novocastra Laboratories). Staining was scored by two experienced pathologists (A. Stenzinger and W.W.). CHK2 staining could be evaluated in all cases; for AURKA expression, 325 cases were evaluable. Cases that showed moderate or strong expression in most tumour cells were scored as positive.
Colony formation assays in soft agar. To analyse anchorage-independent colony formation 6-well culture dishes were coated with 1 ml culture medium containing 1% low-melt agarose (Sigma). Subsequently, 5,000 HCT116 and 2,000 SW620 cells were re-suspended in 1 ml of growth medium containing 0.4% low-melt agarose and plated on top of the solidified bottom layer. Soft agar was overlaid with medium containing Taxol when indicated. The embedded cells were incubated at 37 • C and 5% CO 2 until the arising colonies were stained with 0.001% crystal violet. The growth area was scanned using a Quato IntelliScan 1600 (Quatographic Technology) and colonies were counted by using the Image-Pro Analyser v7.0 Software (Media Cybernetics).
Mice xenografts. HCT116 cells (2 × 10 6 ) in 150 µl PBS were injected s.c. into both flanks of 5-week-old athymic male and female nude mice (Crl:NU-Foxn1 nu, Charles River). For SW620 xenografts, 4 × 10 6 SW620 cells in 200 µl PBS were injected s.c. into both flanks of 6-week-old athymic male and female mice (provided by the MEZ, University of Leipzig, Germany). Growth of two tumours per mouse was monitored regularly by determining the perpendicular diameters of the tumours. All xenograft experiments were performed according to and were approved by the national authorities. The number of tumours analysed is given in the figure legends and in the statistic source data.
Statistical analyses.
All data are shown as mean ± standard deviation (s.d.) or standard error of the mean (s.e.m.). Where indicated Student's t-tests using the Prism software package, version 4 were applied. For the signal intensities at centrosomes, the 95% confidence interval was determined. Statistical analyses on CHK2 and AU-RKA expression patterns in human colorectal cancer tissue samples were performed using SPSS 19.0. and the significance of correlations was determined by applying two-sided Fisher's exact tests. Quantification of mitotic spindles and lagging chromosomes are based on at least 3 independent experiments, in which at least 1,500 mitotic figures or 300 anaphase cells, respectively, were evaluated. All karyotype analyses are based on quantification of individual chromosome numbers from 50-109 metaphase spreads (see also Supplementary Table 1) . No statistical method was used to predetermine sample size. The experiments were not randomized and the investigators were not blinded to allocation during experiments and outcome assessment. Statistic source data are available in Supplementary Table 2 . or CHK2 or the overexpression of AURKA or PLK1 in HCT116 cells after transfection with siRNAs or cDNAs or in knockout cells, respectively. Since full-length APC is hardly detectable in HCT116 cells, we detected Axin-2/conductin, which is strongly induced upon Wnt pathway activation after loss of APC. c, Representative western blot detecting elevated protein levels of Aurora-A in three independent cell clones derived from HCT116 cells stably overexpressing AURKA. d, Increased microtubule plus end assembly rates in bipolar mitotic spindles after loss of CHK2. Asynchronously growing HCT116 and isogenic CHK2 knockout cells were subjected to microtubule assembly rate measurements in bipolar mitotic spindles. No significant difference was observed when compared to monopolar spindles measurements (see e.g. Figure 2 ). Scatter dot plots show average assembly rates based on measurements of 20 microtubules per cell (mean +/-SEM, t-test, n=30 cells from 3 independent experiments). e, Karyotype analyses of single cell clones derived from HCT116 cells stably overexpressing AURKA. Single cell clones were grown for 30 generations and the karyotype was determined (100-102 cells analysed per condition). The proportion of cells showing a deviation of the chromosome numbers from the modal within the defined time span was determined as a measure for chromosomal instability. f, Overexpression of AURKA or loss of CHK2 does not induce supernumerary centrosomes in HCT116 cells. Three independent cell clones overexpressing AURKA or CHK2 knockout cells were investigated for g-tubulin positive interphase centrosomes. HCT116 cells transiently overexpressing PLK4 serve as a control (mean +/-SD; n=2 with a total number of 1000 cells evaluated). g-i, No change in other microtubule dynamic parameters in cells with increased microtubule plus end assembly rates. The indicated cell lines expressing EB3-GFP and treated with 67 μM monastrol were live imaged at a rate of one frame per 300 ms. Microtubule tips were automatically tracked using plusTipTracker software package and g, dynamicity, h, percent of time spent paused and i, catastrophe frequency were determined. The graphs show mean values +/-SE, t-test (n=12 cells for each measurement). Detailed data on karyotype analyses can be found in the Supplementary Table 1 . Statistic source data for Supplementary  Figure 2 can be found in the Supplementary Table 2 . n.s. n.s. n.s. Representative western blots are shown. e, Determination of the specificity of the antibodies used to detect phosphorylated Aurora-A and TACC3. Representative western blots detecting total and active forms of Aurora-A in HCT116 cells synchronized in mitosis (nocodazole 14.5 hours -> MG132 1.5 hours to prevent mitotic exit) after specific inhibition of Aurora-A (0.5 µM MLN8054) or Aurora-B (2 µM ZM447439). Mitotic indices are shown. f, Treatment of mitotic cells with MLN8054 abolishes centrosomal signals for active Aurora-A (pT288). HCT116 cells were treated with DME for 3.5 hours and subsequently treated with DMSO or 0.5 µM MLN8054 for additional 30 min. Total and active (P-Thr-288) Centrosomal Aurora-A was detected by immunofluorescence microscopy (active Aurora-A, red; total Aurora-A, green; DNA, blue; scale bar, 10 µm). Representative examples of immunofluorescence microscopy pictures are shown. g, Specificity of the antibodies used to detect the Aurora-A mediated phosphorylation of TACC3. HCT116 cells were transfected with the indicated siRNAs and synchronized in mitosis by DME treatment and subsequently treated with DMSO or 0.5 µM MLN8054. TACC3 and phosphorylated TACC3 as well as total Aurora-A and active Aurora-A were detected on western blots. Representative western blots are shown. Statistic source data for Supplementary Figure 5 can be found in the Supplementary 
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Supplementary Figure 8 Restoration of normal microtubule assembly rates and chromosomal stability accelerates CRC tumor growth in vitro and in vivo. a-c, Accelerated colony formation activity of SW620 and HCT116-CHK2 -/-cells after partial loss of CH-TOG or AURKA. Stable SW620 cell lines expressing control, CH-TOG shRNAs or AURKA shRNAs were subjected to colony formation assays in soft agar (2,000 cells per well) and colonies were counted. a: 2,000 cells per well, mean +/-SEM, t-test, n=3 independent experiments. b, 5,000 cells per well, mean +/-SEM, t-test, n=4-6, 4-6 independent experiments. c: 2,000 cells per well, mean +/-SEM, t-test, n=4 independent experiments. d-f, Growth of xenograft tumors derived from SW620 or HCT116 cells as indicated with or without partial repression of CH-TOG/CKAP5 or AURKA. The indicated cells were injected s.c. into both flanks of the mice and tumor volumes were determined over time. d, The experiment shown is an extension to the experiment shown in Figure  7c using an independent CH-TOG/CKAP5 shRNA expressing clone (mean +/-SEM, n=14-16 tumors as indicated). e, The experiment shown is an independent extension to the experiment shown in Figure 7d and additional clones were used (mean +/-SEM, n=9-10 tumors as indicated). f, The experiment shown is an independent extension to the experiment shown in Figure 7e and additional clones were used (mean +/-SEM, n=7-11 tumors as indicated). g, Xenograft tumors maintain the partial repression of AURKA in vivo. Cells were re-isolated from three different SW620 xenograft tumors grown in three different mice and expressing control (clone 1) or AURKA shRNAs (clone 1). Cells were subjected to western blotting and protein levels of Aurora-A were detected. Representative western blots are shown. h, Tumor cells re-isolated from xenograft tumors do not show gross alterations in cell cycle distribution. Cells re-isolated from the different xenograft tumors were subjected to FACS analyses and representative cell cycle profiles are shown. i, The suppression of CIN in SW620 cells with reduced AURKA expression is maintained in xenograft tumors in vivo. Tumor cells re-isolated from xenograft tumors were subjected to karyotype analyses (50 cells per condition). Detailed data on karyotype analyses can be found in the Supplementary Table 1 . Statistic source data for Supplementary Figure 7 can be found in the Supplementary Table 2 .
